National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

melanoma helper peptide vaccine
A multivalent vaccine consisting of peptides derived from melanoma-associated antigens and an adjuvant peptide derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic T-cell response against tumor cells expressing melanoma-associated antigens, resulting in tumor cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:MHP VAC



Previous:MEK inhibitor AZD8330, MEK inhibitor GSK1120212, MEK inhibitor RDEA119, MEK inhibitor XL518, Melan-A VLP vaccine
Next:meloxicam, melphalan, memantine hydrochloride, menatetrenone, menogaril

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov